Clinical Trial Update: SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) [Phase 2]

View source ↗

Summary

Phase 2 trial SCH 727965 in advanced breast cancer and non-small-cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• SCH 727965

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED